Claus M. Larsen

2.8k total citations · 1 hit paper
12 papers, 2.2k citations indexed

About

Claus M. Larsen is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Claus M. Larsen has authored 12 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Claus M. Larsen's work include Pancreatic function and diabetes (8 papers), Diabetes and associated disorders (3 papers) and Adipose Tissue and Metabolism (3 papers). Claus M. Larsen is often cited by papers focused on Pancreatic function and diabetes (8 papers), Diabetes and associated disorders (3 papers) and Adipose Tissue and Metabolism (3 papers). Claus M. Larsen collaborates with scholars based in Denmark, Sweden and United States. Claus M. Larsen's co-authors include Thomas Mandrup‐Poulsen, Allan Vaag, Mirjam Faulenbach, Marc Y. Donath, Jan A. Ehses, Aage Vølund, Burkhardt Seifert, Henrik U. Andersen, Karin Wadt and Natalie Hiscock and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Diabetes Care.

In The Last Decade

Claus M. Larsen

12 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus

2007 1.4k citations Claus M. Larsen, Mirjam Faulenbach et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claus M. Larsen Denmark	10	846	728	611	595	537	12	2.2k
Marina Cardellini Italy	30	1.1k 1.3×	607 0.8×	420 0.7×	315 0.5×	260 0.5×	56	2.6k
Stéphanie Bonnafous France	25	1.0k 1.2×	1.7k 2.3×	436 0.7×	464 0.8×	259 0.5×	34	3.1k
Yasunori Takata Japan	26	811 1.0×	470 0.6×	497 0.8×	296 0.5×	154 0.3×	90	2.2k
T. Toyota Japan	27	490 0.6×	407 0.6×	727 1.2×	235 0.4×	252 0.5×	64	2.2k
Miina K. Öhman United States	20	520 0.6×	431 0.6×	459 0.8×	204 0.3×	272 0.5×	34	1.7k
AnneMarie Gagnon Canada	29	866 1.0×	579 0.8×	327 0.5×	233 0.4×	134 0.2×	66	2.5k
Frédéric Leprêtre France	21	690 0.8×	473 0.6×	244 0.4×	155 0.3×	405 0.8×	47	1.8k
Søren A. Urhammer Denmark	32	1.2k 1.4×	428 0.6×	829 1.4×	127 0.2×	603 1.1×	50	2.6k
Pili Zhang United States	18	637 0.8×	371 0.5×	626 1.0×	185 0.3×	335 0.6×	22	1.5k
David Vicent Spain	19	899 1.1×	340 0.5×	331 0.5×	156 0.3×	195 0.4×	37	2.0k

Countries citing papers authored by Claus M. Larsen

Since Specialization

Citations

This map shows the geographic impact of Claus M. Larsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus M. Larsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus M. Larsen more than expected).

Fields of papers citing papers by Claus M. Larsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claus M. Larsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus M. Larsen. The network helps show where Claus M. Larsen may publish in the future.

Co-authorship network of co-authors of Claus M. Larsen

This figure shows the co-authorship network connecting the top 25 collaborators of Claus M. Larsen. A scholar is included among the top collaborators of Claus M. Larsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claus M. Larsen. Claus M. Larsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Larsen, Claus M., Mirjam Faulenbach, Allan Vaag, et al.. (2010). Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra. Clinical Proteomics. 6(4). 153–161. 1 indexed citations

Larsen, Claus M., Mirjam Faulenbach, Allan Vaag, et al.. (2009). Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes. Diabetes Care. 32(9). 1663–1668. 308 indexed citations

Berchtold, Lukas Adrian, Claus M. Larsen, Allan Vaag, et al.. (2009). IL-1 receptor antagonism and muscle gene expression in patients with type 2 diabetes. European Cytokine Network. 20(2). 81–87. 10 indexed citations

Brøns, Charlotte, Christine B. Jensen, Heidi Storgaard, et al.. (2009). Impact of short‐term high‐fat feeding on glucose and insulin metabolism in young healthy men. The Journal of Physiology. 587(10). 2387–2397. 215 indexed citations

Rønn, Sif G., Christine Bruun, Claus M. Larsen, et al.. (2008). IL-1β-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells. Diabetologia. 52(2). 281–288. 20 indexed citations

Larsen, Claus M., Mirjam Faulenbach, Allan Vaag, et al.. (2007). [Interleukin-1 receptor antagonist-treatment of patients with type 2 diabetes].. PubMed. 169(45). 3868–71. 13 indexed citations

Larsen, Claus M., Mirjam Faulenbach, Allan Vaag, et al.. (2007). Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus. New England Journal of Medicine. 356(15). 1517–1526. 1390 indexed citations breakdown →

Larsen, Claus M., Martin Døssing, Salvatore Papa, et al.. (2006). Growth arrest- and DNA-damage-inducible 45β gene inhibits c-Jun N-terminal kinase and extracellular signal-regulated kinase and decreases IL-1β-induced apoptosis in insulin-producing INS-1E cells. Diabetologia. 49(5). 980–989. 33 indexed citations

Larsen, Claus M., et al.. (2000). TNFα and IFNγ potentiate IL-1β induced mitogen activated protein kinase activity in rat pancreatic islets of Langerhans. Diabetologia. 43(11). 1389–1396. 32 indexed citations

10.

Larsen, Claus M., Karin Wadt, Henrik U. Andersen, et al.. (1998). Interleukin-1β-induced Rat Pancreatic Islet Nitric Oxide Synthesis Requires Both the p38 and Extracellular Signal-regulated Kinase 1/2 Mitogen-activated Protein Kinases. Journal of Biological Chemistry. 273(24). 15294–15300. 140 indexed citations

11.

Wadt, Karin, Claus M. Larsen, Henrik U. Andersen, et al.. (1998). Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.. Diabetes. 47(10). 1602–1608. 37 indexed citations

12.

Mauricio, Dı́dac, Henrik U. Andersen, Claus M. Larsen, et al.. (1997). DEXAMETHASONE PREVENTS INTERLEUKIN-1β-MEDIATED INHIBITION OF RAT ISLET INSULIN SECRETION WITHOUT DECREASING NITRIC OXIDE PRODUCTION. Cytokine. 9(8). 563–569. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact